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Background: Duplex evaluations of success are usually descriptive
using terms like abolition of reflux and obliteration. Many patients however,
have mixed patterns of treatment effect which are difficult to compare. A
simple and flexible treatment scoring system is proposed, the saphenous
treatment score (STS), which references the pre- and post-treatment evalu-
ation of the above (AK) and below knee (BK) part of the great saphenous
vein. Analysis of the change in STS may then provide a numerical value of
effectiveness that can be used for standardizing treatment comparisons
between studies.
Methods: Sixty-six consecutive patients with great saphenous vein
(GSV) reflux (0.5 seconds) received either endo-venous laser therapy with
concurrent phlebectomies or ultrasound-guided foam sclerotherapy with up
to 12mL of 1% STD foam. Patients with lesser saphenous or deep vein reflux
or a history of deep vein thrombosis were excluded. Assessments were
Table I. Analysis on 66 patients undergoing primary treat
Saphenous Treatment Score Median (range)
Mean (
confidence
Pre 6 (4-6) 5.7 (5.5
Post 3 (2-6) 3.30 (3.0
Difference 2 (0-4) 2.39 (2.1
Aberdeen Varicose Vein Questionnaire Median (ran
Pre 21.52 (0.86-52
Post 18.86 (5.50-66
Venous Clinical Severity Score Median (range)
Pre 6 (2-20)
Post 3 (0-10)
Table II. Subgroup analysis on the 15 patients requiring a
Saphenous
Treatment Score Median (range)
Mean (95% confidence
interval)
Pre 6 (5-6) 5.8 (5.57-6.03)
Post 1 4 (2-6) 4.13 (3.58-4.68) D
Post 2 3 (2-4) 2.6 (2.25-2.95) D
P
Venous filling index (mL/s) Median (range)
Pre 6.3 (1.4-15)
Post 2 1.9 (0.3-3.7)
Table III. Three-week primary difference in mean Saphen
and 28 ultrasound-guided foam sclerotherapy patients
Difference in mean
Saphenous Treatment Score
Endo-venous laser therapy
(95% confidence interval)
Ultra
Above knee 1.92 (1.83-2.01)
Below knee 0.87 (0.57-1.17)
Total 2.79 (2.46-3.12)P  .0005 (Wilcoxon) P performed before and after treatment using the Aberdeen varicose vein
questionnaire, the venous clinical severity score, the venous filling index
using air plethysmography, and the saphenous treatment score using duplex.
The AK and BK segments of the GSV were individually graded: 3, 2, or 1
representing the presence of reflux, patency with no reflux, or occlusion,
respectively. Mixed patterns were weighted with a score of 3 having prefer-
ence over both 1 and 2, and 1 having preference over 2. This gives a final
saphenous treatment score of between 6 and 2 for the GSV. The difference
in mean STS before and after treatment is presented.
Results: These results demonstrate the difference in mean STS com-
pared against other assessment parameters (Table I), ongoing treatments
(Table II), and between different treatments (Table III).
Conclusions: The STS is based on scoring the presence of reflux,
patency/competency, and occlusion. It can grade the effects of treatment
on the GSV both above and below the knee. We have shown a different
numeric score for foam compared with laser in the management of
primary GSV reflux at 3 weeks. Further studies incorporating the lesser
saphenous vein into the scoring will provide us with a global score of
effectiveness in the management of the saphenous trunks of the ex-
tremity.
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